Omicron named a SARS-CoV-2 variant of concern by WHO
The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE), independent experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assess mutations and...
Antibiotic-resistant infections have fallen for the first time since 2016
New data by the UK Health Security Agency (UKHSA) shows that antibiotic-resistant bloodstream infections fell in 2020, from 65,583 in 2019 to 55,384. However,...
Risk of COVID-19 infection steadily increases after second vaccine dose
A research team based in Israel has identified that the risk of infection from COVID-19 gradually increases after receiving a second vaccine dose.
Research emerging...
COVID-19 demonstrates the ability to infect an unborn baby
Researchers have identified that an unborn baby can potentially contract COVID-19 infection, uncovering the mechanism behind catching the virus.
A study, led by researchers from...
Scientists say plant-derived drug is effective in blocking SARS-CoV-2 Delta variant
A recent discovery by scientists at the University of Nottingham has found that a plant-based antiviral treatment is effective at treating all variants of...
Combatting Crimean-Congo haemorrhagic fever with COVID technology
A scientific research consortium called Prometheus is employing the same framework used to develop COVID-19 vaccines to tackle Crimean-Congo haemorrhagic fever.
Crimean-Congo haemorrhagic fever (CCHF)...
SSRI antidepressants observed to protect COVID-19 patients from death
Novel research from the US has identified that SSRI antidepressants may possess qualities that help to reduce deaths in COVID-19 patients.
In a study conducted...
Investigating the impacts of COVID-19 variants on dialysis treatment
A team of international researchers has examined the efficacy of COVID-19 vaccines for patients undergoing dialysis treatment.
The study, led by experts at the Marien...
Vaccines to be compulsory for frontline NHS staff in England
The Health and Social Care Secretary, Sajid Javid, has announced that NHS staff will be required to be fully vaccinated against COVID-19 unless they...
Licensing agreed by University of Birmingham for COVID nasal spray
The University of Birmingham has signed a licensing agreement with Birmingham Biotech Ltd to commercialise an anti-viral COVID nasal spray that can offer protection...
US approves vaccine for COVID-19 in children over five
The US has recommended that children aged five to 11 be vaccinated against COVID-19 with the Pfizer-BioNTech vaccine, allowing providers to begin the vaccination...
Pfizer/BioNTech booster vaccine reduces COVID-19 hospitalisations
In the most extensive real-world study to date, an international research team has identified that the Pfizer/BioNTech booster vaccine is highly effective at reducing...
Exploring how natural killer cells can enhance wound healing
Christian Stockmann, Assistant Professor at the University of Zurich, outlines his recent research into natural killer cells and how these cells can be harnessed...
Uncovering why the COVID-19 Delta Variant is exceptionally infectious
Research emerging from the United States has revealed what makes the dreaded COVID-19 Delta Variant so infectious, a breakthrough that may help to design...
How can we alleviate the burden of antibiotic resistance?
Professor Colin Garner, CEO of charity Antibiotic Research UK, discusses how enhancing knowledge can help to mitigate antibiotic resistance.
Antibiotic resistance is a growing public...
Why sepsis awareness matters in the fight to save lives
With early diagnosis being vital in the treatment of sepsis, Sepsis Alliance shares how they are working to raise awareness of the condition’s associated...
COVID-19 antibodies significantly boosted in double vaccinated individuals
A study conducted in Sweden has elucidated that although COVID-19 antibodies are reduced in the airways following SARS-CoV-2 infection, two vaccine doses increase these...
Medical professionals urge the public to get the influenza vaccine
A plethora of critical care and pulmonary societies are advising the public to receive the influenza vaccine as we edge closer to the flu...
Forecasting COVID-19 hospitalisations and deaths with cell discovery
A team of scientists has made a novel cell discovery that may be able to predict the probability of COVID-19 hospitalisations and deaths.
The University...
Cutting-edge face shield destroys SARS-CoV-2 and multi-resistant bacteria
A team of researchers based in Spain have developed an innovative face shield that effectively deactivates SARS-CoV-2 and multi-resistant bacteria.
The groundbreaking face shield technology...
